SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 9 filers reported holding SEAGEN INC in Q4 2023. The put-call ratio across all filers is 0.99 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,035,729 | +32.6% | 19,023 | +20.3% | 0.22% | +36.8% |
| Q2 2023 | $3,043,562 | +0.8% | 15,814 | +6.0% | 0.16% | -12.8% |
| Q1 2023 | $3,019,638 | +0.4% | 14,914 | -36.3% | 0.19% | -4.1% |
| Q4 2022 | $3,008,805 | -6.0% | 23,413 | +0.1% | 0.20% | -15.2% |
| Q3 2022 | $3,200,000 | -26.0% | 23,388 | -4.3% | 0.23% | -16.4% |
| Q2 2022 | $4,325,000 | +8.0% | 24,446 | -12.0% | 0.28% | +63.7% |
| Q1 2022 | $4,003,000 | -23.4% | 27,790 | -17.8% | 0.17% | -1.8% |
| Q4 2021 | $5,225,000 | -18.3% | 33,800 | -10.3% | 0.17% | -20.8% |
| Q3 2021 | $6,398,000 | +11.5% | 37,680 | +3.6% | 0.22% | +11.9% |
| Q2 2021 | $5,739,000 | +10.4% | 36,355 | -2.9% | 0.19% | -3.5% |
| Q1 2021 | $5,198,000 | -19.2% | 37,431 | +2.0% | 0.20% | -28.8% |
| Q4 2020 | $6,430,000 | – | 36,715 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |